The effect of glycosaminoglycans on the in vitro activity of human skin fibroblast glycosphingolipid beta-galactosidases and neuraminidases.
The apparent low level of synthetic substrate beta-D-galactosidase activity in liver from patients with the Hurler-Hunter syndrome is caused by the inhibitory effect of accumulated glycosaminoglycans. We have demonstrated complete inhibition of GM1 ganglioside beta-galactosidase activity in vitro by both heparan sulfate and dermatan sulfate, but the effect on lactosylceramide and galactosylceramide hydrolysis was less marked. In contrast, lysosomal neuraminidase activity in vitro was enhanced by the addition of glycosaminoglycans. These observations are discussed in relationship to the observed storage pattern of glycosphingolipids in liver from patients with mucopolysaccharidoses.
D002478:Cells, Cultured; D005347:Fibroblasts / Q000201:enzymology; D005696:Galactosidases / Q000037:antagonists & inhibitors*; D006025:Glycosaminoglycans / Q000494:pharmacology*; D006028:Glycosphingolipids; D006801:Humans; D066298:In Vitro Techniques; D008059:Mucopolysaccharidosis I / Q000201:enzymology; D016532:Mucopolysaccharidosis II / Q000201:enzymology; D009084:Mucopolysaccharidosis III / Q000201:enzymology; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D012867:Skin / Q000201:enzymology*; D001616:beta-Galactosidase / Q000037:antagonists & inhibitors*
D006025:Glycosaminoglycans; D006028:Glycosphingolipids; D005696:Galactosidases; D009439:Neuraminidase; D001616:beta-Galactosidase